Phase 3 trial results published in European Journal of Heart Failure identify key target population for Mesoblast allogeneic cell therapy…
VAPI, India, Nov. 27, 2024 /PRNewswire/ -- Meril Life Sciences, a leading global med-tech company specializing in cardiovascular and structural…
VAPI, India, Nov. 27, 2024 /PRNewswire/ -- Meril Life Sciences, a leading global med-tech company specializing in cardiovascular and structural…
VAPI, India, Nov. 27, 2024 /PRNewswire/ -- Meril Life Sciences, a leading global med-tech company specializing in cardiovascular and structural…
VAPI, India, Nov. 27, 2024 /PRNewswire/ -- Meril Life Sciences, a leading global med-tech company specializing in cardiovascular and structural…
VAPI, India, Nov. 27, 2024 /PRNewswire/ -- Meril Life Sciences, a leading global med-tech company specializing in cardiovascular and structural…
VAPI, India, Nov. 27, 2024 /PRNewswire/ -- Meril Life Sciences, a leading global med-tech company specializing in cardiovascular and structural…
Breathtaking 100-meter-wide anamorphic art piece in Sharjahâs Al Madam area by acclaimed artist David Popa brings new collection to lifeOne-of-a-kind…
Heart disease in dogs is almost as common as it is in humans, affecting approximately 10 percent of dogs in…
Heart disease in dogs is almost as common as it is in humans, affecting approximately 10 percent of dogs in…